USpharma Ltd.

USpharma Ltd. is a multi-national, science driven organization with over 100 employees worldwide. We are a development-stage, specialty pharmaceutical company with industry leading product expertise focused in the areas of Central Nervous System (CNS) disorders, including transdermal patches for ADHD and pain management; complemented by research activities. USpharma Ltd. purchased the Miami Lakes site from Merck Sharp and Dohme Corporation in April 2017 and relocated their headquarters to Miami Lakes, Florida effective May 2017. USpharma is now the only manufacturer of NITRO-DUR® Transdermal Patches, used to prevent chest pain (angina) in people with certain heart conditions (coronary artery disease). In addition to Transdermal products, the company's other areas of focus are Solid and Liquid Dosage forms. 
​